allulose benefits glp 1 Is a GLP-1 Agonist? Evidence and Key Differences GLP-1 release and vagal afferent

The differential impact of three different NAD(+) boosters on circulatory NAD and microbial metabolism in humans

*Compounded medications are prepared at the direction of your Affinity healthcare provider and are not governed by the FDA

doi: 10.1210/jc.2009-2724

GLP-1 and Fatty Liver Disease (NAFLD/NASH) GLP-1RAs show promising benefits in: Hepatic steatosis reduction Weight loss-mediated liver improvement Improved insulin resistance Reduced inflammation These agents are likely to become central therapies in metabolic-associated steatotic liver disease (MASLD)

Groundbreaking research published in Science in 2024 revealed a novel gutjoint axis mechanism for osteoarthritis treatment via GLP-1-mediated pathways

Tell your anaesthetist if youre scheduled for surgery